Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_4
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
4(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 44 (100.0%)

Trials by Status

recruiting125%
completed250%
unknown125%

Recent Activity

1 active trials
Showing 4 of 4
completedphase_4

The RESTORE Study, A Randomized, Controlled, Masked (Reading Center) Prospective Study

NCT04396990
completedphase_4

DEXTENZA for the Treatment of Postoperative Pain and Inflammation Following Vitreo-retinal Surgery

NCT04462523
recruitingphase_4

The PRIME Study: A Randomized, Controlled, Prospective Study

NCT04549935
unknownphase_4

DEXTENZA Compared to Topical Prednisolone in Patients Undergoing Bilateral LASIK Surgery

NCT04281862

Clinical Trials (4)

Showing 4 of 4 trials
NCT04396990Phase 4

The RESTORE Study, A Randomized, Controlled, Masked (Reading Center) Prospective Study

Completed
NCT04462523Phase 4

DEXTENZA for the Treatment of Postoperative Pain and Inflammation Following Vitreo-retinal Surgery

Completed
NCT04549935Phase 4

The PRIME Study: A Randomized, Controlled, Prospective Study

Recruiting
NCT04281862Phase 4

DEXTENZA Compared to Topical Prednisolone in Patients Undergoing Bilateral LASIK Surgery

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4